Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/ANTX

    AN2 Therapeutics, Inc.(ANTX)

    Biotechnology
    Infectious Disease Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    56.2
    Insider Trading Score
    Peer Group Scores
    REGN
    78
    ANTX
    56
    PFE
    56
    NTLA
    50
    TGTX
    50
    LIANY
    50
    SPRO
    49
    EDIT
    49
    RGNX
    48
    SGMO
    36
    QURE
    24
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2026-06-02
    Williams Sarah Joanne
    Principal Accounting Officer
    Sale
    -265
    -0.40%66,583
    $4.43$1,174View SEC filing
    2026-03-05
    Williams Sarah Joanne
    Principal Accounting Officer
    Sale
    -327
    -0.49%66,848
    $1.06$347View SEC filing
    2026-01-07
    Day Lucy
    Chief Financial Officer
    Sale
    -8,807
    -10.46%75,363
    $1.01$8,883View SEC filing
    2026-01-07
    Prior Stephen David
    Chief Strategy Officer
    Sale
    -6,462
    -9.86%59,086
    $1.01$6,507View SEC filing
    2026-01-07
    Chanda Sanjay
    Chief Development Officer
    Sale
    -9,251
    -10.87%75,823
    $1.01$9,332View SEC filing
    2026-01-07
    Eizen Joshua M
    See Remarks
    Sale
    -24,854
    -14.01%152,499
    $1.00$24,962View SEC filing
    2025-11-06
    Eizen Joshua M
    See Remarks
    Sale
    -2,819
    -1.56%177,353
    $1.14$3,214View SEC filing
    2025-11-06
    Prior Stephen David
    Chief Strategy Officer
    Sale
    -765
    -1.15%65,548
    $1.14$872View SEC filing
    2025-06-16
    Leonard Braden Michael
    10% Owner
    Sale
    -200,000
    -6.22%3,017,432
    $1.09$218,000View SEC filing
    2025-06-03
    Easom Eric
    Chief Executive Officer
    Purchase
    +10,000
    +4.06%256,380
    $1.07$10,665View SEC filing
    2025-05-30
    Leonard Braden Michael
    10% Owner
    Sale
    -2,532,000
    -44.04%3,217,432
    $1.13$2,872,477View SEC filing
    2025-05-29
    FitzPatrick Margaret M
    Director
    Purchase
    +8,610
    +100.00%8,610
    $1.18$10,133View SEC filing
    2025-01-07
    Day Lucy
    Chief Financial Officer
    Sale
    -2,957
    -8.30%32,670
    $1.34$3,965View SEC filing
    2025-01-07
    Chanda Sanjay
    Chief Development Officer
    Sale
    -2,957
    -9.02%29,824
    $1.34$3,965View SEC filing
    2025-01-07
    Prior Stephen David
    Chief Strategy Officer
    Sale
    -2,029
    -5.74%33,313
    $1.34$2,721View SEC filing
    2025-01-07
    Eizen Joshua M
    See Remarks
    Sale
    -9,663
    -7.65%116,672
    $1.34$12,958View SEC filing
    2024-12-10
    Readnour Robin Shane
    Director
    Purchase
    +60,000
    +18.16%652,573
    $1.45$86,708View SEC filing
    2024-11-27
    Readnour Robin Shane
    Director
    Purchase
    +75,000
    +20.94%622,573
    $1.41$105,685View SEC filing
    2024-11-27
    Zakrzewski Joseph S
    Director
    Purchase
    +2,000
    +1.62%125,199
    $1.40$2,800View SEC filing
    2024-11-21
    Readnour Robin Shane
    Director
    Purchase
    +200,000
    +6.13%514,788
    $1.07$213,128View SEC filing
    2024-11-20
    Zakrzewski Joseph S
    Director
    Purchase
    +25,000
    +25.46%123,199
    $1.00$25,046View SEC filing
    2024-11-18
    Easom Eric
    Chief Executive Officer
    Purchase
    +50,000
    +4.92%1,065,766
    $1.00$49,970View SEC filing
    2024-08-14
    Leonard Braden Michael
    10% Owner
    Purchase
    +1,500,000
    +35.30%5,749,432
    $1.04$1,560,000View SEC filing
    2024-08-13
    RA Capital Healthcare Fund LP
    10% Owner
    Sale
    -3,525,094
    -94.14%300,853
    $1.08$3,807,102View SEC filing
    2024-01-19
    Zakrzewski Joseph S
    Director
    Sale
    -100,000
    -19.77%405,880
    $19.11$1,911,410View SEC filing

    1-25 of 62

    Page 1 of 3